308 related articles for article (PubMed ID: 23064657)
1. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
[TBL] [Abstract][Full Text] [Related]
2. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
3. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
[TBL] [Abstract][Full Text] [Related]
5. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
6. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
[TBL] [Abstract][Full Text] [Related]
7. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
[TBL] [Abstract][Full Text] [Related]
8. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.
Liu WN; Fu KL; Gao HY; Shang YY; Wang ZH; Jiang GH; Zhang Y; Zhang W; Zhong M
PLoS One; 2012; 7(7):e37659. PubMed ID: 22815685
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
[TBL] [Abstract][Full Text] [Related]
10. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
[TBL] [Abstract][Full Text] [Related]
11. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
Yu WP; Lou M; Deng B; Song HM; Wang HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
[TBL] [Abstract][Full Text] [Related]
12. Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors.
McLean RC; Baird SW; Becker LC; Townsend SN; Gerstenblith G; Kass DA; Tomaselli GF; Schulman SP
Am J Cardiol; 2012 Oct; 110(7):1001-7. PubMed ID: 22742717
[TBL] [Abstract][Full Text] [Related]
13. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
14. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias.
Ulucan C; Cetintas V; Tetik A; Eroglu Z; Kayikcioglu M; Can LH; Payzin S; Aydin M; Hasdemir C
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1053-8. PubMed ID: 18479335
[TBL] [Abstract][Full Text] [Related]
15. Impact of beta-2 Thr164Ile and combined beta-adrenergic receptor polymorphisms on prognosis in a cohort of heart failure outpatients.
Biolo A; Salvaro R; Clausell N; Silvello D; Santos KG; Rohde LE
Braz J Med Biol Res; 2010 Jun; 43(6):565-71. PubMed ID: 20521014
[TBL] [Abstract][Full Text] [Related]
16. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopathy.
Metaxa S; Missouris C; Mavrogianni D; Miliou A; Oikonomou E; Toli E; Kormali L; Vlismas A; Drakakis P; Tousoulis D
Curr Vasc Pharmacol; 2018; 16(6):618-623. PubMed ID: 28933308
[TBL] [Abstract][Full Text] [Related]
18. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
19. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure.
Chemello D; Rohde LE; Santos KG; Silvello D; Goldraich L; Pimentel M; Rosa PR; Zimerman L; Clausell N
Europace; 2010 May; 12(5):686-91. PubMed ID: 20185488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
